IBDEI0LX ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10397,1,3,0)
 ;;=3^Conjunctivitis,Inclusion
 ;;^UTILITY(U,$J,358.3,10397,1,4,0)
 ;;=4^077.0
 ;;^UTILITY(U,$J,358.3,10397,2)
 ;;=^27600
 ;;^UTILITY(U,$J,358.3,10398,0)
 ;;=077.1^^44^565^61
 ;;^UTILITY(U,$J,358.3,10398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10398,1,3,0)
 ;;=3^Keratoconjunctivitis,Epidemic EKC
 ;;^UTILITY(U,$J,358.3,10398,1,4,0)
 ;;=4^077.1
 ;;^UTILITY(U,$J,358.3,10398,2)
 ;;=^41251
 ;;^UTILITY(U,$J,358.3,10399,0)
 ;;=077.8^^44^565^37
 ;;^UTILITY(U,$J,358.3,10399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10399,1,3,0)
 ;;=3^Conjunctivitis,Viral,Oth
 ;;^UTILITY(U,$J,358.3,10399,1,4,0)
 ;;=4^077.8
 ;;^UTILITY(U,$J,358.3,10399,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,10400,0)
 ;;=078.5^^44^565^46
 ;;^UTILITY(U,$J,358.3,10400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10400,1,3,0)
 ;;=3^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,10400,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,10400,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,10401,0)
 ;;=090.3^^44^565^59
 ;;^UTILITY(U,$J,358.3,10401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10401,1,3,0)
 ;;=3^Keratitis,Interstitial,Syphilitic
 ;;^UTILITY(U,$J,358.3,10401,1,4,0)
 ;;=4^090.3
 ;;^UTILITY(U,$J,358.3,10401,2)
 ;;=^266697
 ;;^UTILITY(U,$J,358.3,10402,0)
 ;;=091.50^^44^565^93
 ;;^UTILITY(U,$J,358.3,10402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10402,1,3,0)
 ;;=3^Uveitis Syphilitica,Unspec
 ;;^UTILITY(U,$J,358.3,10402,1,4,0)
 ;;=4^091.50
 ;;^UTILITY(U,$J,358.3,10402,2)
 ;;=^266715
 ;;^UTILITY(U,$J,358.3,10403,0)
 ;;=094.83^^44^565^83
 ;;^UTILITY(U,$J,358.3,10403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10403,1,3,0)
 ;;=3^Retinochoroiditis,Dissem,Syphilitic
 ;;^UTILITY(U,$J,358.3,10403,1,4,0)
 ;;=4^094.83
 ;;^UTILITY(U,$J,358.3,10403,2)
 ;;=^266752
 ;;^UTILITY(U,$J,358.3,10404,0)
 ;;=099.3^^44^565^82
 ;;^UTILITY(U,$J,358.3,10404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10404,1,3,0)
 ;;=3^Reiter's Disease
 ;;^UTILITY(U,$J,358.3,10404,1,4,0)
 ;;=4^099.3
 ;;^UTILITY(U,$J,358.3,10404,2)
 ;;=^104534
 ;;^UTILITY(U,$J,358.3,10405,0)
 ;;=112.89^^44^565^5
 ;;^UTILITY(U,$J,358.3,10405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10405,1,3,0)
 ;;=3^Candida,Oth
 ;;^UTILITY(U,$J,358.3,10405,1,4,0)
 ;;=4^112.89
 ;;^UTILITY(U,$J,358.3,10405,2)
 ;;=^87368
 ;;^UTILITY(U,$J,358.3,10406,0)
 ;;=136.1^^44^565^1
 ;;^UTILITY(U,$J,358.3,10406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10406,1,3,0)
 ;;=3^Behcet's Disease
 ;;^UTILITY(U,$J,358.3,10406,1,4,0)
 ;;=4^136.1
 ;;^UTILITY(U,$J,358.3,10406,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,10407,0)
 ;;=190.3^^44^565^11
 ;;^UTILITY(U,$J,358.3,10407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10407,1,3,0)
 ;;=3^Conjunctiva Malig Neopl
 ;;^UTILITY(U,$J,358.3,10407,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,10407,2)
 ;;=^267274
 ;;^UTILITY(U,$J,358.3,10408,0)
 ;;=198.89^^44^565^91
 ;;^UTILITY(U,$J,358.3,10408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10408,1,3,0)
 ;;=3^Uveal Metastasis
 ;;^UTILITY(U,$J,358.3,10408,1,4,0)
 ;;=4^198.89
 ;;^UTILITY(U,$J,358.3,10408,2)
 ;;=^267330
 ;;^UTILITY(U,$J,358.3,10409,0)
 ;;=202.80^^44^565^64
 ;;^UTILITY(U,$J,358.3,10409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10409,1,3,0)
 ;;=3^Lymphoma,Extranod/Solid Org,Unspec Site
 ;;^UTILITY(U,$J,358.3,10409,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,10409,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,10410,0)
 ;;=224.3^^44^565^12
 ;;^UTILITY(U,$J,358.3,10410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10410,1,3,0)
 ;;=3^Conjunctiva,Benign Neopl
 ;;^UTILITY(U,$J,358.3,10410,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,10410,2)
 ;;=^267673
 ;;
 ;;$END ROU IBDEI0LX
